|
PDK3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.06019999998897E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.036100E-04 |
| Normal-vs-Stage2 |
9.458300E-02 |
| Normal-vs-Stage3 |
1.69783999999229E-05 |
| Normal-vs-Stage4 |
2.96560000001556E-06 |
| Stage1-vs-Stage2 |
6.116000E-01 |
| Stage1-vs-Stage3 |
2.012000E-01 |
| Stage1-vs-Stage4 |
3.197900E-02 |
| Stage2-vs-Stage3 |
2.468000E-01 |
| Stage2-vs-Stage4 |
6.046200E-02 |
| Stage3-vs-Stage4 |
2.355800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02379999999958E-06 |
| Normal-vs-AfricanAmerican |
9.620700E-03 |
| Normal-vs-Asian |
2.705000E-03 |
| Caucasian-vs-AfricanAmerican |
4.316000E-01 |
| Caucasian-vs-Asian |
4.451000E-01 |
| AfricanAmerican-vs-Asian |
2.812600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.477200E-03 |
| Normal-vs-Female |
1.63909999995049E-06 |
| Male-vs-Female |
1.765840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.438100E-04 |
| Normal-vs-Age(41-60Yrs) |
9.75749999999609E-05 |
| Normal-vs-Age(61-80Yrs) |
4.186400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.164840E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.239600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.140400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.853200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.049200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.785000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.569200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.864200E-01 |
| Classical-VS-Follicular |
1.91546778438578E-12 |
| Classical-VS-Other |
1.768000E-02 |
| Classical-VS-Normal |
5.37989996995947E-09 |
| Tall-VS-Follicular |
3.29629999962222E-08 |
| Tall-VS-Other |
2.082300E-03 |
| Tall-VS-Normal |
8.023499999954E-07 |
| Follicular-VS-Other |
7.980000E-01 |
| Follicular-VS-Normal |
3.412600E-01 |
| Other-VS-Normal |
4.285200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.103600E-03 |
| Normal-vs-N1 |
2.602100E-03 |
| N0-vs-N1 |
6.981600E-01 |
|
|
